Suchergebnisse - "Audigier-Valette, Clarisse"

PubPharm (14)

1

Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations : Results From the IFCT Biomarkers France Study

enthalten in: Clinical lung cancer | 2023

von Mordant, P. | Brosseau, S. | Milleron, B. | +16

2

Detection of acquired TERT amplification in addition to predisposing p53 and Rb pathways alterations in EGFR-mutant lung adenocarcinomas transformed into small-cell lung cancers

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2022

von Mc Leer, A. | Foll, M. | Brevet, M. | +12

3

Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC : IFCT-1003 LADIE Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2020

von Mazieres, J. | Barlesi, F. | Rouquette, I. | +20

4

Phase II Study Evaluating the Mechanisms of Resistance on Tumor Tissue and Liquid Biopsy in Patients With EGFR-mutated Non-pretreated Advanced Lung Cancer Receiving Osimertinib Until and Beyond Radiologic Progression : The MELROSE Trial

enthalten in: Clinical lung cancer | 2020

von Bennouna, J. | Girard, N. | Audigier-Valette, C. | +17

5

Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung : The LUX-Lung IO/KEYNOTE 497 Study Protocol

enthalten in: Clinical lung cancer | 2019

von Levy, B. | Paz-Ares, L. | Bennouna, J. | +17

6

Association between lung cancer somatic mutations and occupational exposure in never-smokers

enthalten in: The European respiratory journal | 2017

von Paris, C. | Do, P. | Mastroianni, B. | +92

CommentIn: Eur Respir J. 2018 Mar 8;51(3):. - PMID 29519903

7

EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice

enthalten in: The European respiratory journal | 2017

von Tomasini, P. | Brosseau, S. | Mazières, J. | +17

CommentIn: Transl Lung Cancer Res. 2017 Dec;6(Suppl 1):S39-S40. - PMID 29299407

8

Routine molecular profiling of patients with advanced non-small-cell lung cancer : results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT)

enthalten in: Lancet (London, England) | 2016

von Barlesi, F. | Mazieres, J. | Merlio, J. | +30

CommentIn: Lancet. 2016 Apr 2;387(10026):1354-6. - PMID 26777918

9

Rebiopsy during disease progression in patients treated by TKI for oncogene-addicted NSCLC

enthalten in: Targeted oncology | 2015

von Bosc, C. | Ferretti, G. | Cadranel, J. | +7

10

No impact of passive smoke on the somatic profile of lung cancers in never-smokers

enthalten in: The European respiratory journal | 2015

von Couraud, S. | Debieuvre, D. | Moreau, L. | +87

CommentIn: Eur Respir J. 2015 May;45(5):1214-7. - PMID 25931484